C

Zimmer Biomet Holdings, Inc. ZBH

$93.98 -$0.34-0.36% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Zimmer Biomet Holdings, Inc. is a global medical technology company focused on musculoskeletal healthcare. The company develops, manufactures, and markets orthopedic reconstructive products, musculoskeletal biologics, sports medicine products, extremities and trauma devices, office-based technologies, and digital and robotic solutions used by orthopedic surgeons and healthcare providers. Zimmer Biomet operates primarily within the medical devices and healthcare technology industries, with significant exposure to joint reconstruction, surgical robotics, and patient care management markets.

The company’s principal revenue drivers include knee and hip replacement implants, surgical technologies, robotic-assisted surgery systems, and related medical devices used in orthopedic procedures. Its major customer base includes hospitals, ambulatory surgery centers, orthopedic surgeons, and healthcare systems globally. Zimmer Biomet traces its origins to Zimmer Manufacturing Company, founded in 1927 in Indiana, and expanded significantly through acquisitions and product diversification. A defining event in its evolution was the 2015 merger between Zimmer Holdings, Inc. and Biomet, Inc., creating one of the world’s largest orthopedic device manufacturers. The company positions itself competitively through a broad implant portfolio, surgeon relationships, extensive distribution networks, and integration of robotics and digital surgical technologies.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Wednesday, August 5, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)

Price History

Loading...
52-Week Range54% of range
Low
$79.12
Current
$93.98
High
$106.88
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)

Corporate Info

Phone Number
574 373 3333
Address
345 East Main Street
Warsaw, IN 46580
Country
Year Founded

Headlines

9/17/2026 - Zacks Investment Research